We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Vindon H. | VDN | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 13.25 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 13.25 | 13.25 |
| Top Posts |
|---|
Posted at 31/10/2013 22:22 by buywell2 SBS now trading at 10.75pSellers of VDN stock that ploughed their cash into SBS shares would have done OK it seems |
Posted at 11/10/2013 22:07 by buywell2 So no interims from Vindon and no dividendPresumably the profit and dividend payment that were to happen now get ploughed into SBS , now trading at 10p |
Posted at 02/9/2013 11:47 by piedro Mr Yeung Yu Loong has now increased his SBS holding to 5.55%Any VDN holders or ex-holders have any comments on Source BioSciences. |
Posted at 29/8/2013 07:45 by buywell2 Vindon is going to belong to Source BioScience PiedroThat you have most likely lost money on your investment is not my fault and is no excuse for being rude What you have to decide is whether you want to become a SBS shareholder, if you believe enough in the Vindon story that you have written here on advfn thus far that you still want to carry on with it albeit under another name but still with the VDN CEO on the board Check out SBS results today |
Posted at 22/8/2013 07:29 by buywell2 Have you sold your VDN shares Piedro yet ? |
Posted at 15/8/2013 11:49 by piedro Thank you, Mr. Yeung was of the opposition note then.He does make some interesting points which are well worth being considered by SBS shareholders - IMHO In the offer document (downloadable from the VDN website) it is stated that SBS intends to continue with Vindon's current activities and that their places of business and fixed assets will remain unchanged. Also most of Vindon's directors and senior management will remain in the enlarged group As Mr. Yeung points out, this will change the nature of SBS and suggest to me that perhaps they also are struggling to find their niche |
Posted at 12/8/2013 16:00 by piedro Article in the ShareSoc Informerre: Source BioScience offer for VDN hxxp://www.sharesoc. ... you may need to register to read the article (free) ... not everyone is in agreement |
Posted at 23/7/2013 12:14 by piedro VDN California website now available |
Posted at 16/7/2013 13:22 by piedro buywell2,Thank you. This certainly seems a good deal for Source BioScience but as a shareholder of VDN I feel disappointed - cash 13.70p and shut up !!! Not even a share offer. Re: the SBS bb, perhaps you could start a new one as that available is not very pleasant. |
Posted at 16/7/2013 09:55 by buywell2 You have been ploughing a lone furrow for many years PiedroYour hard work has not gone unnoticed Welcome to the SBS fold My take is that with SBS using VDN storage facilities in the USA , and Ireland to sell SBS Life Sciences products , antibodies/clones/re www.sourcebioscience Also SBS have been expanding their DNA sequencing services at a pace , profits up circa 50% from this year on year .... they can now do the same from the two USA VDN bases and thus tap into the BIGGEST Pharma Biotech CRO area in the WORLD. Plus cross selling opportunities to each others Client Lists means the 'Collective' after assimilation should be more than the sum of each of the individuals within 12 months. Vindon will be the 5th SBS acquisition ..... Turnover for the first 6 months announced next month should be UP 30%. They are going places ..... check out the recent Institutional holdings taken in the company in the last 12 to 18 months. Some BIG names have bought in Major Shareholders holding over 3% ... Shares in issue :203.8m 2p Ords Name .................... TD Direct Investing (Europe) 21,000,000 ....10.0 Henderson Global Investors .. 12,095,215 ..... 5.9 Mr S Varkey .................. 3,522,581 ..... 1.73 Seren Capital Manag't ....... 10,675,000 ..... 6.6 SBS Directors/Snr Manag't ....14,222,897 ..... 7.38 Killik & Co LLP ............. 10,586,131 ..... 5.20 Blackrock Inv't Manag't ..... 10,715,000 ..... 5.26 Legal & Gen Assurance ....... 16,637,876 ..... 8.16 Barclays Bank Plc (Pvte Bing) 9,300,000 ...... 4.2 Standard Life Investments .... 9,500,000 ..... 4.66 Mr Yeung Yu Loong ........... 8,528,228 ...... 4.16 Swedbank Robur .............. 6,000,000 ...... 2.94 Talos Securities Ltd. ....... 5,900,000 ...... 2.9% 69% Per cent of shares held by top holders Source BioScience makes a strong start to the year 12 June 2013 | 14:47pm StockMarketWire.com - Source BioScience, which reported further growth and increased profitability in 2012, has made a good start to this year. Laurie Turnbull, chairman, told today's AGM: "Demand from the NHS for our diagnostic services continues to be strong and year to date revenue has increased by over 35% compared with the same period last year. "We remain one of only a small number of accredited laboratories in Europe with access to the technologies and expertise required to deliver complex gene-based diagnostic testing for cancer and other diseases, which affords us commercial advantage." Mr Turnbull also commented that the company enjoyed a leading position in the UK for the provision of DNA sequencing services and remain the only company offering a UK-based sequencing service. He added: "This part of our business will be boosted by the expansion of our service into Scotland, enabling us to offer our overnight service for DNA sequencing to the local research community. Hope this sits well Bro |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
